It has also been shown that BRAF inhibitor resistance can be mediated by regulatory escape of the transcription factor MITF from the MAPK pathway, where MITF overexpression itself conferred resistance in several melanoma cell lines (Van Allen et al., 2014). Here, BRAF is linked to melanoma.